Co-diagnostics, inc. to present at marketsandmarkets conference on march 23-24 in london, england

Salt lake city , march 22, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will present at the 3rd annual marketsandmarkets infectious disease diagnostics and molecular diagnostics conference, held march 23-24, 2022, in london, england. co-diagnostics ceo dwight egan will be presenting on the company's yourtest™ pcr at-home/point-of-care testing device to the international audience at 14:00 gmt on march 23rd.
CODX Ratings Summary
CODX Quant Ranking